anmelden
Next CAC 70
3.519,63
PKT
-17,55
PKT
-0,50
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu Next CAC 70-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.02.22 | Airbus Buy | Jefferies & Company Inc. | |
| 09.02.22 | BNP Paribas Outperform | Credit Suisse Group | |
| 09.02.22 | Airbus Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.02.22 | Engie (ex GDF Suez) Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.02.22 | Air Liquide Buy | Goldman Sachs Group Inc. | |
| 08.02.22 | BNP Paribas Buy | UBS AG | |
| 08.02.22 | AXA Overweight | Morgan Stanley | |
| 08.02.22 | BNP Paribas Buy | Jefferies & Company Inc. | |
| 08.02.22 | BNP Paribas Neutral | JP Morgan Chase & Co. | |
| 08.02.22 | ING Group Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.02.22 | Sanofi Equal Weight | Barclays Capital | |
| 08.02.22 | VINCI Overweight | Barclays Capital | |
| 08.02.22 | Airbus Buy | Jefferies & Company Inc. | |
| 07.02.22 | Holcim Hold | Jefferies & Company Inc. | |
| 07.02.22 | Renault Hold | Deutsche Bank AG | |
| 07.02.22 | VINCI Buy | Deutsche Bank AG | |
| 07.02.22 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 07.02.22 | Sanofi Outperform | Credit Suisse Group | |
| 07.02.22 | ING Group Buy | UBS AG | |
| 07.02.22 | VINCI Buy | Goldman Sachs Group Inc. | |
| 07.02.22 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.02.22 | AIR France-KLM Neutral | UBS AG | |
| 07.02.22 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 07.02.22 | VINCI Overweight | JP Morgan Chase & Co. | |
| 04.02.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 04.02.22 | ING Group Underweight | Barclays Capital | |
| 04.02.22 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.02.22 | Sanofi Buy | UBS AG | |
| 04.02.22 | VINCI Buy | UBS AG | |
| 04.02.22 | Sanofi Outperform | Bernstein Research | |
| 04.02.22 | VINCI Outperform | RBC Capital Markets | |
| 04.02.22 | Renault Overweight | JP Morgan Chase & Co. | |
| 04.02.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 04.02.22 | VINCI Buy | Goldman Sachs Group Inc. | |
| 04.02.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 04.02.22 | VINCI Overweight | JP Morgan Chase & Co. | |
| 04.02.22 | Renault Neutral | Goldman Sachs Group Inc. | |
| 04.02.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 04.02.22 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 04.02.22 | Publicis Buy | Goldman Sachs Group Inc. |
